• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

General construction pattern of histamine H3-receptor antagonists: change of a paradigm.

作者信息

Stark H, Ligneau X, Arrang J M, Schwartz J C, Schunack W

机构信息

Institut für Pharmazie I, Freie Universität Berlin, Germany.

出版信息

Bioorg Med Chem Lett. 1998 Aug 4;8(15):2011-6. doi: 10.1016/s0960-894x(98)00342-4.

DOI:10.1016/s0960-894x(98)00342-4
PMID:9873477
Abstract

Novel omega-phenyl substituted and unsubstituted alkyl and alkenyl imidazole derivatives were prepared and tested for their antagonist activity in vitro and in vivo at histamine H3-receptors. Some compounds showed high in vitro and in vivo H3-receptor activity despite their structure bearing no polar moiety in the centre of the molecule which is a common structural feature of all other antagonists known. Quite probably there are further in vivo effects for some compounds resulting from other receptor interactions.

摘要

相似文献

1
General construction pattern of histamine H3-receptor antagonists: change of a paradigm.
Bioorg Med Chem Lett. 1998 Aug 4;8(15):2011-6. doi: 10.1016/s0960-894x(98)00342-4.
2
Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.作为组胺H3受体拮抗剂的取代N-苯基氨基甲酸酯,其体内效价得到提高。
Pharmazie. 2000 Feb;55(2):83-6.
3
Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.具有羰基取代的4-(3-(苯氧基)丙基)-1H-咪唑结构的新型组胺H(3)受体拮抗剂,如西普西兰及相关化合物。
J Med Chem. 2000 Oct 19;43(21):3987-94. doi: 10.1021/jm000966l.
4
4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.4-炔基苯基咪唑基丙基醚作为具有高口服中枢神经系统活性的选择性组胺H3受体拮抗剂。
J Med Chem. 1998 Oct 8;41(21):4171-6. doi: 10.1021/jm9802970.
5
Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.手性N-烷基氨基甲酸酯作为强效和选择性H3受体拮抗剂新先导化合物的开发:合成、毛细管电泳以及体外和口服体内活性
J Med Chem. 1999 Feb 25;42(4):593-600. doi: 10.1021/jm9804376.
6
Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.西普罗芬的类似物和衍生物,一种用于生成强效组胺H3受体拮抗剂的新型原型。
Bioorg Med Chem Lett. 2000 Oct 16;10(20):2379-82. doi: 10.1016/s0960-894x(00)00473-x.
7
Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.FUB 181的研发,一种具有4-(ω-(芳基烷氧基)烷基)-1H-咪唑结构的高口服体内活性的选择性组胺H3受体拮抗剂。
Arch Pharm (Weinheim). 1998 Jun;331(6):211-8. doi: 10.1002/(sici)1521-4184(199806)331:6<211::aid-ardp211>3.0.co;2-p.
8
New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.普罗西泮系列新型组胺H(3)受体配体:咪普罗西泮及其他具有高口服体内活性的选择性拮抗剂。
J Med Chem. 2000 Aug 24;43(17):3335-43. doi: 10.1021/jm000971p.
9
Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.普罗西凡类药物的研究进展:杂环同系物作为新型强效和选择性组胺H(3)受体拮抗剂
Eur J Pharm Sci. 2002 May;15(4):367-78. doi: 10.1016/s0928-0987(02)00024-6.
10
Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships.
Arch Pharm (Weinheim). 1996 Aug-Sep;329(8-9):379-85. doi: 10.1002/ardp.19963290802.

引用本文的文献

1
Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain.大鼠和人类组胺H(3)受体的不同药理学特性:第三个跨膜结构域中两个氨基酸的作用。
Br J Pharmacol. 2000 Dec;131(7):1247-50. doi: 10.1038/sj.bjp.0703712.